涉脑机接口热点信息披露不准确、不完整，亚辉龙及董事会秘书遭上交所监管警示

Group 1 - The Shanghai Stock Exchange issued a regulatory warning to YHLO (688575) and its then Secretary of the Board, Wang Mingyang, due to discrepancies in the company's disclosures regarding a strategic cooperation framework agreement with Shenzhen Brain Machine Starlink Technology Co., Ltd. [1] - YHLO announced a strategic cooperation with Brain Machine Starlink, focusing on product development, market promotion, and equity investment, highlighting the company's engagement in artificial intelligence and non-invasive/invasive technology paths [1][2] - Following media attention, YHLO issued a supplementary announcement clarifying that Brain Machine Starlink's current research products are based solely on non-invasive technology, with some products still in early development or preclinical stages [1][2] Group 2 - The "brain-computer interface" is currently a hot market concept, attracting significant investor interest, which led to a 6.52% increase in YHLO's stock price and a 299% rise in trading volume on the day of the announcement [2] - The Shanghai Stock Exchange emphasized the need for YHLO to ensure that disclosures regarding the cooperation with Brain Machine Starlink are accurate, complete, and not misleading, particularly given the inconsistencies in the statements about the invasive technology path [2] - The exchange noted that YHLO's announcements failed to adequately address key investor concerns regarding the feasibility and uncertainties of the collaboration, leading to the regulatory warning [2]